Variant report
Variant | nsv459529 |
---|---|
Chromosome Location | chr2:141321160-141350100 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 2)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:141323740..141325865-chr2:141332665..141335542,2 | MCF-7 | breast: | |
2 | chr2:141337531..141339093-chr2:141342570..141345467,2 | MCF-7 | breast: | |
3 | chr2:141323740..141325865-chr2:141332665..141335542,2 | MCF-7 | breast: | |
4 | chr2:141314211..141315888-chr2:141319868..141321651,2 | MCF-7 | breast: | |
5 | chr2:141337531..141339093-chr2:141342570..141345467,2 | MCF-7 | breast: |
No data |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-7157-3p | chr2:141344195-141344216 | MIMAT0028225 |
hsa-miR-7157-5p | chr2:141344232-141344254 | MIMAT0028224 |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535462589 | chr2:141332029-141332030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs555365551 | chr2:141332142-141332143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575616418 | chr2:141332167-141332168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544468958 | chr2:141332189-141332190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538638685 | chr2:141332272-141332273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189138364 | chr2:141332298-141332299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192101971 | chr2:141332324-141332325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577754498 | chr2:141332326-141332327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143267700 | chr2:141332416-141332417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112213405 | chr2:141332433-141332434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs1352043 | chr2:141332441-141332442 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs184282916 | chr2:141332446-141332447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541836894 | chr2:141332457-141332458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs35799401 | chr2:141332521-141332522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1352045 | chr2:141332522-141332523 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs35836885 | chr2:141335005-141335006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531684937 | chr2:141335006-141335007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12464264 | chr2:141335039-141335040 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs188225433 | chr2:141335067-141335068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543296383 | chr2:141335079-141335080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116741381 | chr2:141335124-141335125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112051598 | chr2:141335128-141335129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548343470 | chr2:141335132-141335133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544803477 | chr2:141335175-141335176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs13019155 | chr2:141335224-141335225 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs34871884 | chr2:141335228-141335229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192913172 | chr2:141335235-141335236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34789509 | chr2:141335237-141335238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557070060 | chr2:141335239-141335240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560498445 | chr2:141335244-141335245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184628336 | chr2:141335254-141335255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs115752552 | chr2:141335273-141335274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569782770 | chr2:141335288-141335289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs532314463 | chr2:141335366-141335367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552060696 | chr2:141335382-141335383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10928756 | chr2:141335425-141335426 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs534245521 | chr2:141335426-141335427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs59559230 | chr2:141335500-141335501 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs10928757 | chr2:141335596-141335597 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs189509810 | chr2:141335639-141335640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs371855247 | chr2:141335667-141335668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536987285 | chr2:141335679-141335680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs556793319 | chr2:141335731-141335732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs13411843 | chr2:141335750-141335751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545599593 | chr2:141335806-141335807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs66723917 | chr2:141335832-141335833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs78020597 | chr2:141335841-141335842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs35188978 | chr2:141335876-141335877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558843428 | chr2:141335940-141335941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572107910 | chr2:141335941-141335942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Cancer | 20164920 | CNVD |
Hypertension | 22686481 | CNVD |
Hypospadia | 22686481 | CNVD |
Intellectual disability | 22686481 | CNVD |
Omphalocele | 22686481 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:141332000-141332600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr2:141335000-141335600 | Enhancers | Liver | Liver |
3 | chr2:141335600-141336000 | Weak transcription | Liver | Liver |
4 | chr2:141336000-141336200 | Enhancers | Liver | Liver |
5 | chr2:141336200-141338600 | Weak transcription | Liver | Liver |
6 | chr2:141336400-141336600 | Enhancers | Adipose Nuclei | Adipose |
7 | chr2:141337800-141339400 | Enhancers | Hela-S3 | cervix |
8 | chr2:141338000-141338200 | Enhancers | Fetal Intestine Large | intestine |
9 | chr2:141338000-141339200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr2:141338200-141338800 | Enhancers | Adipose Nuclei | Adipose |
11 | chr2:141338400-141338800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
12 | chr2:141338400-141339400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr2:141338600-141339000 | Enhancers | Liver | Liver |
14 | chr2:141338800-141339000 | Enhancers | Fetal Intestine Large | intestine |
15 | chr2:141341600-141342400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr2:141342000-141342600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
17 | chr2:141347000-141347600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |